RWS Holdings plc announced the launch of the Fonto Integrated Authoring Platform (IAP), a game-changing solution designed to streamline the document creation and publishing process for the pharmaceutical industry. Fonto transforms the complex and time-consuming task of drafting, editing and reviewing critical business documents - including regulatory submissions and drug applications - into a straightforward, efficient process. Its user-friendly interface, similar to Microsoft Word, allows experts to collaborate centrally, enhancing the speed and quality of document production.

Fonto IAP seamlessly integrates with external data sources, automating the creation of working documents. It also ensures consistency of content through templates and standardization, ensuring all documents are compliant with regulatory requirements.